https://sputnikglobe.com/20211230/us-to-clear-pfizers-covid-19-booster-vaccine-for-12-15-year-old-adolescents---reports-1091921199.html
US to Clear Pfizer's COVID-19 Booster Vaccine for 12-15 Year Old Adolescents - Reports
US to Clear Pfizer's COVID-19 Booster Vaccine for 12-15 Year Old Adolescents - Reports
Sputnik International
The US Food and Drug Administration (FDA) is planning to allow the Pfizer coronavirus "booster" vaccines to be used on 12 to 15-year-old adolescents
2021-12-30T17:27+0000
2021-12-30T17:27+0000
2021-12-30T17:27+0000
vaccinations
booster
food and drug administration (fda)
https://cdn1.img.sputnikglobe.com/img/07e5/0c/08/1091341700_0:139:3070:1866_1920x0_80_0_0_3678af2bd322781927b1eef5688dd9d5.jpg
The FDA is also expected to cut the period of time after which both, adolescents and adults can get Pfizer's booster shot six months to five months after their second vaccine dose, the report said.In addition, the FDA will also authorize booster shots for children with immune deficiencies in the 5-11 age range, the report said.The vaccine advisory committee of the Centers for Disease Control and Prevention will be meeting next week to vote on the changes in case FDA endorses them.On Wednesday, the US authorities reported nearly 500,000 coronavirus cases amid the growing prevalence of the Omicron variant. Health experts have said the Omicron variant cases are mild and no deaths have so far been reported.
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
vaccinations, booster, food and drug administration (fda)
vaccinations, booster, food and drug administration (fda)
US to Clear Pfizer's COVID-19 Booster Vaccine for 12-15 Year Old Adolescents - Reports
WASHINGTON (Sputnik) - The US Food and Drug Administration (FDA) is planning to allow the Pfizer coronavirus "booster" vaccines to be used on 12 to 15-year-old adolescents, the New York Times reported on Thursday.
The FDA is also expected to cut the period of time after which both, adolescents and adults can get Pfizer's booster shot six months to five months after their second vaccine dose, the report said.
In addition, the FDA will also authorize booster shots for children with immune deficiencies in the 5-11 age range, the report said.
The vaccine advisory committee of the Centers for Disease Control and Prevention will be meeting next week to vote on the changes in case FDA endorses them.
On Wednesday, the US authorities reported nearly 500,000 coronavirus cases amid the growing prevalence of the Omicron variant. Health experts have said the Omicron variant cases are mild and no deaths have so far been reported.
